Galderma to acquire Q-Med

Dermatology company Galderma S.A. (Lausanne, Switzerland) will acquire medical device company Q-Med AB (SSE:QMED) for up to SEK7.5 billion ($1.1 billion) in cash in a tender offer. Galderma said Q-Med will become its center of excellence for the field of corrective and aesthetic dermatology. Q-Med, which had 2009 revenues of SEK1.4 billion, markets Restylane for filling lines and folds, contouring and creating volume in the face, and Macrolane for body contouring. ...